Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenzaJohn H. Powers, Guillermo M. Ruiz‐Palacios, Patricia Rodríguez‐Zulueta et al.|BMC Infectious Diseases|2015Cited by 514
De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical PhenotypeVandana Shashi, Jennifer E. Posey, Loren D.M. Peña et al.|The American Journal of Human Genetics|2016Cited by 87
A clustering of heterozygous missense variants in the crucial chromatin modifier WDR5 defines a new neurodevelopmental disorderLot Snijders Blok, Tjitske Kleefstra, Jolijn Verseput et al.|Human Genetics and Genomics Advances|2022Cited by 10
Pathogenic variants in SMARCA1 cause an X-linked neurodevelopmental disorder modulated by NURF complex compositionDavid J. Picketts, Tjitske Kleefstra, Ghayda Mirzaa et al.|Research Square|2023Cited by 4